vs
盛美半导体（ACMR）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是盛美半导体的1.6倍（$382.2M vs $244.4M），盛美半导体净利率更高（3.3% vs 3.1%，领先0.2%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 9.4%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $20.1M），过去两年盛美半导体的营收复合增速更高（26.7% vs 12.8%）
盛美半导体（ACM Research, Inc.）是全球领先的半导体制造设备供应商，专注于研发、生产及销售晶圆湿法处理相关设备，覆盖清洗、电镀、刻蚀等品类，产品广泛应用于逻辑、存储、功率等各类先进芯片的生产流程，服务全球多地区芯片制造企业。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
ACMR vs LFST — 直观对比
营收规模更大
LFST
是对方的1.6倍
$244.4M
营收增速更快
LFST
高出8.0%
9.4%
净利率更高
ACMR
高出0.2%
3.1%
自由现金流更多
LFST
多$26.5M
$20.1M
两年增速更快
ACMR
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $244.4M | $382.2M |
| 净利润 | $8.0M | $11.7M |
| 毛利率 | 40.9% | — |
| 营业利润率 | 9.4% | 4.7% |
| 净利率 | 3.3% | 3.1% |
| 营收同比 | 9.4% | 17.4% |
| 净利润同比 | -74.1% | 264.1% |
| 每股收益（稀释后） | $0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACMRLFST
| Q4 25 | $244.4M | $382.2M | ||
| Q3 25 | $269.2M | $363.8M | ||
| Q2 25 | $215.4M | $345.3M | ||
| Q1 25 | $172.3M | $333.0M | ||
| Q4 24 | $223.5M | $325.5M | ||
| Q3 24 | $204.0M | $312.7M | ||
| Q2 24 | $202.5M | $312.3M | ||
| Q1 24 | $152.2M | $300.4M |
净利润ACMRLFST
| Q4 25 | $8.0M | $11.7M | ||
| Q3 25 | $35.9M | $1.1M | ||
| Q2 25 | $29.8M | $-3.8M | ||
| Q1 25 | $20.4M | $709.0K | ||
| Q4 24 | $31.1M | $-7.1M | ||
| Q3 24 | $30.9M | $-6.0M | ||
| Q2 24 | $24.2M | $-23.3M | ||
| Q1 24 | $17.4M | $-21.1M |
毛利率ACMRLFST
| Q4 25 | 40.9% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 48.5% | — | ||
| Q1 25 | 47.9% | — | ||
| Q4 24 | 49.6% | — | ||
| Q3 24 | 51.4% | — | ||
| Q2 24 | 47.8% | — | ||
| Q1 24 | 52.0% | — |
营业利润率ACMRLFST
| Q4 25 | 9.4% | 4.7% | ||
| Q3 25 | 10.7% | 2.0% | ||
| Q2 25 | 14.7% | -0.9% | ||
| Q1 25 | 15.0% | 0.5% | ||
| Q4 24 | 19.7% | 0.3% | ||
| Q3 24 | 21.7% | 0.0% | ||
| Q2 24 | 18.6% | -5.1% | ||
| Q1 24 | 16.6% | -5.6% |
净利率ACMRLFST
| Q4 25 | 3.3% | 3.1% | ||
| Q3 25 | 13.3% | 0.3% | ||
| Q2 25 | 13.8% | -1.1% | ||
| Q1 25 | 11.8% | 0.2% | ||
| Q4 24 | 13.9% | -2.2% | ||
| Q3 24 | 15.2% | -1.9% | ||
| Q2 24 | 12.0% | -7.5% | ||
| Q1 24 | 11.5% | -7.0% |
每股收益（稀释后）ACMRLFST
| Q4 25 | $0.11 | — | ||
| Q3 25 | $0.52 | — | ||
| Q2 25 | $0.44 | — | ||
| Q1 25 | $0.30 | — | ||
| Q4 24 | $0.47 | — | ||
| Q3 24 | $0.45 | — | ||
| Q2 24 | $0.35 | — | ||
| Q1 24 | $0.26 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $792.9M | $248.6M |
| 总债务越低越好 | $214.0M | $282.8M |
| 股东权益账面价值 | $1.5B | $1.5B |
| 总资产 | $2.9B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资ACMRLFST
| Q4 25 | $792.9M | $248.6M | ||
| Q3 25 | $1.1B | $203.9M | ||
| Q2 25 | $463.2M | $188.9M | ||
| Q1 25 | $475.6M | $134.3M | ||
| Q4 24 | $426.8M | $154.6M | ||
| Q3 24 | $353.8M | $102.6M | ||
| Q2 24 | $343.6M | $87.0M | ||
| Q1 24 | $230.0M | $49.5M |
总债务ACMRLFST
| Q4 25 | $214.0M | $282.8M | ||
| Q3 25 | $242.0M | $284.6M | ||
| Q2 25 | $225.1M | $286.4M | ||
| Q1 25 | $202.5M | $288.2M | ||
| Q4 24 | $150.0M | $290.0M | ||
| Q3 24 | $150.0M | $287.3M | ||
| Q2 24 | $90.5M | $288.0M | ||
| Q1 24 | $60.0M | $288.8M |
股东权益ACMRLFST
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.4B | $1.5B | ||
| Q2 25 | $986.5M | $1.5B | ||
| Q1 25 | $949.1M | $1.5B | ||
| Q4 24 | $904.6M | $1.4B | ||
| Q3 24 | $888.2M | $1.4B | ||
| Q2 24 | $833.2M | $1.4B | ||
| Q1 24 | $796.2M | $1.4B |
总资产ACMRLFST
| Q4 25 | $2.9B | $2.2B | ||
| Q3 25 | $2.8B | $2.1B | ||
| Q2 25 | $2.0B | $2.1B | ||
| Q1 25 | $1.9B | $2.1B | ||
| Q4 24 | $1.9B | $2.1B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.7B | $2.1B | ||
| Q1 24 | $1.6B | $2.1B |
负债/权益比ACMRLFST
| Q4 25 | 0.15× | 0.19× | ||
| Q3 25 | 0.17× | 0.19× | ||
| Q2 25 | 0.23× | 0.19× | ||
| Q1 25 | 0.21× | 0.20× | ||
| Q4 24 | 0.17× | 0.20× | ||
| Q3 24 | 0.17× | 0.20× | ||
| Q2 24 | 0.11× | 0.20× | ||
| Q1 24 | 0.08× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.9M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $20.1M | $46.6M |
| 自由现金流率自由现金流/营收 | 8.2% | 12.2% |
| 资本支出强度资本支出/营收 | 5.6% | 2.9% |
| 现金转化率经营现金流/净利润 | 4.21× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-66.6M | $110.0M |
8季度趋势，按日历期对齐
经营现金流ACMRLFST
| Q4 25 | $33.9M | $57.6M | ||
| Q3 25 | $-4.6M | $27.3M | ||
| Q2 25 | $-44.9M | $64.4M | ||
| Q1 25 | $5.3M | $-3.1M | ||
| Q4 24 | $88.6M | $62.3M | ||
| Q3 24 | $11.9M | $22.7M | ||
| Q2 24 | $61.6M | $44.1M | ||
| Q1 24 | $-9.6M | $-21.8M |
自由现金流ACMRLFST
| Q4 25 | $20.1M | $46.6M | ||
| Q3 25 | $-15.6M | $17.0M | ||
| Q2 25 | $-59.6M | $56.6M | ||
| Q1 25 | $-11.4M | $-10.3M | ||
| Q4 24 | $77.2M | $56.0M | ||
| Q3 24 | $-20.6M | $17.7M | ||
| Q2 24 | $48.5M | $39.0M | ||
| Q1 24 | $-35.1M | $-26.9M |
自由现金流率ACMRLFST
| Q4 25 | 8.2% | 12.2% | ||
| Q3 25 | -5.8% | 4.7% | ||
| Q2 25 | -27.7% | 16.4% | ||
| Q1 25 | -6.6% | -3.1% | ||
| Q4 24 | 34.5% | 17.2% | ||
| Q3 24 | -10.1% | 5.7% | ||
| Q2 24 | 24.0% | 12.5% | ||
| Q1 24 | -23.0% | -9.0% |
资本支出强度ACMRLFST
| Q4 25 | 5.6% | 2.9% | ||
| Q3 25 | 4.1% | 2.8% | ||
| Q2 25 | 6.8% | 2.2% | ||
| Q1 25 | 9.7% | 2.2% | ||
| Q4 24 | 5.1% | 1.9% | ||
| Q3 24 | 16.0% | 1.6% | ||
| Q2 24 | 6.5% | 1.6% | ||
| Q1 24 | 16.7% | 1.7% |
现金转化率ACMRLFST
| Q4 25 | 4.21× | 4.93× | ||
| Q3 25 | -0.13× | 25.34× | ||
| Q2 25 | -1.51× | — | ||
| Q1 25 | 0.26× | -4.36× | ||
| Q4 24 | 2.85× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 2.54× | — | ||
| Q1 24 | -0.55× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACMR
| Total Single Wafer And Semi Critical Cleaning Equipment | $159.9M | 65% |
| ECP Front End And Packaging Furnace And Other Technologies | $64.1M | 26% |
| Advanced Packaging Exclude ECP Services Spares | $20.5M | 8% |
LFST
暂无分部数据
